•
Jun 30, 2021

Acadia Healthcare Q2 2021 Earnings Report

Acadia Healthcare reported strong financial and operating performance due to increased demand and focus on efficiencies.

Key Takeaways

Acadia Healthcare reported revenue of $582.2 million for the second quarter of 2021, a significant increase from $491.5 million in the same period last year. Net income attributable to Acadia stockholders was $44.5 million, or $0.49 per diluted share, compared to $41.1 million, or $0.46 per diluted share, for the second quarter of 2020. The company is increasing financial guidance for 2021.

Revenue increased to $582.2 million compared to $491.5 million for the second quarter of 2020.

Adjusted EBITDA increased 25.2% to $141.3 million.

Net income attributable to Acadia stockholders was $44.5 million, or $0.49 per diluted share.

Acadia added 86 beds to its operations, including 72 from the opening of a replacement facility for Belmont Behavioral Hospital.

Total Revenue
$582M
Previous year: $750M
-22.4%
EPS
$0.71
Previous year: $0.54
+31.5%
US Same Facility Revenue Growth
18%
Previous year: -3.4%
-629.4%
US Same Facility Patient Days Growth
9.8%
Previous year: -0.7%
-1500.0%
US Rev. per Patient Day Growth
7.5%
Previous year: -2.7%
-377.8%
Gross Profit
$250M
Previous year: $293M
-14.5%
Cash and Equivalents
$186M
Previous year: $212M
-12.5%
Free Cash Flow
$36.2M
Previous year: $146M
-75.2%
Total Assets
$4.56B
Previous year: $6.83B
-33.2%

Acadia Healthcare

Acadia Healthcare

Forward Guidance

Acadia increased the Company’s financial guidance for 2021 to reflect the strong operating and financial performance for the first six months of the year and its expectations for the remainder of the year, as follows: